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Sickle cell disease is an inherited disorder that affects red 
blood cells. People with sickle cell disease have red blood cells that 
contain mostly hemoglobin S, an abnormal type of hemoglobin. The most 
common form found in North America is homozygous Hb S disease, first 
described by Herrick in 1910. Hemoglobin – is the main substance of the 
red blood cells. It helps red blood cells carry oxygen from the air in our 
lungs to all parts of the body. Normal red blood cells contain hemoglobin 
A. Hemoglobin S and Hemoglobin C are abnormal type of hemoglobin. 
Sometimes these red blood cells become sickle cell shaped (crescent 
shaped) and have difficulty passing through small blood vessels. When 
sickle-shaped cells block small vessels, less blood can reach that part of 
the body. Tissue that does not receive a normal blood flow eventually 
becomes damaged. This is what causes the complications of sickle cell 
disease. There is currently no universal cure for sickle cell disease. 
Normal red blood cells are soft and round and can squeeze through tiny 
blood tubes (vessels). Normally, red blood cells live for about 120 days 
before new ones replace them. People with sickle cell conditions make a 
different form of hemoglobin A called hemoglobin S (S stands for sickle). 
Red blood cells containing mostly hemoglobin S do not live as long as 
normal red blood cells (normally about 16 days).[1] 
Sickle cell disease usually begins in early childhood. 
Characteristic features of this disorder include a low number of red 
blood cells (anemia), repeated infections, and periodic episodes of pain. 
The severity of symptoms varies from person to person. Some people 
have mild symptoms, while others are frequently hospitalized for more 
serious complications. (U.S. National Library of Medicine February 
2007). Sickle cells condition are inherited from parents in much the 
same way as blood type, hair color and texture, eye color and other 
physical traits. The type of hemoglobin a person makes in the red blood 
cells depends upon what hemoglobin genes the person inherits from his 
or her parents. Like most genes, hemoglobin genes are inherited in two 
sets one from each parent. 
Cells with a markedly increased Hb S concentration are a 
prominent feature of sickle cell disease, as a consequence of the loss of 
K, Cl and water from the erythrocyte. The extreme dependence of 
polymerization kinetics on Hb S concentration means that these 
dehydrated erythrocytes rapidly sickle when deoxygenated. Blockade of 
K loss from the erythrocyte should, therefore, prevent the increase in Hb 
S concentration and reduce erythrocyte sickling. Detailed knowledge of 
the mechanisms leading to cell dehydration makes this a viable 
therapeutic option. Two ion transport pathways, the K-Cl co-transport 
and the Ca activated K channel play prominent roles in the dehydration 
of sickle erythrocytes. Possible therapeutic strategies include inhibition 
of K-Cl co-transport by increasing red cell Mg content and inhibition of 
the Ca activated K channel by oral administration of clotrimazole.[1] 
The blood sample from total number of 30 patients was 
collected. RBC will be separated on the basis of gravity by Percoll 
gradient method. Glutathione contents (reduced/oxidized) will be 
determined by HPLC method by lysis of RBC. 
 To fractionate erythrocyte from normal and sickle cell disease 
patients on the basis of their density by Percoll gradient. 
 To estimate levels reduced glutathione and oxidized glutathione in 
fractionated erythrocytes by HPLC. 
 
2. Materials and methods 
2.1 Sample collection: 
Blood was collected from 30 different Sickle Cell Disease 
Patients from Seesha Hospital Coimbatore by venipuncture to the 
antecubial vein with a 23- gauge butterfly needle attached to a 5ml 
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syringe. Approximately 2ml blood was drawn into the syringe, the 
butterfly needle is removed (while the syringe remains attached to the 
needle), and the venipuncture site is covered with gauze. The subject 
was asked to hold the gauze while the collector removes and disposal of 
the butterfly needle and drips 2ml of blood into an EDTA vial. Collected 
sample were stored at -800C as soon as possible for storage. 
 2.2 Sample processing 
  2ml of blood from the collected sample was then spun in a 
centrifuge at 1200 RPM for 5 mins in a 15ml centrifugation tube. The 
supernatant obtained (plasma) was then removed by the help of pipette. 
The pellet obtained was the whole blood cells. The pellet was collected 
in a different tube and was mixed with an equal amount of PBS solution. 
The tube was gently inverted twice for mixing and stored at -400C. 
2.3 Percoll gradient separation: 
2.3.1 Stock solution of Percoll: 
To prepare a gradient the osmolarity of Percoll was adjusted 
with saline medium to make Percoll isotonic with physiological salt 
solutions by adding 9 parts (v/v) of Percoll to 1 Part (v/v) of 1.5 M NaCl 
and a Stock Isotonic Percoll (SIP) solution was made. 
2.3.2 Gradient separation: 
RBCs were separated into fraction based on cell density 
centrifugation. In a 15 ml tube, 2 ml of a solution of Percoll having a 
density of 1.115 g ml- 1 were added to the bottom of the tube. Next, 2 ml 
of a similar solution of Percoll having a density of 1.105 g ml- 1 were 
slowly added on to the top of the first 2 ml of the higher density solution. 
Finally, 1 ml of RBCs was added to the top of the Percoll layers. The 
tubes’ containing the Percoll and RBCs was then centrifuged at 7500 
RPM for 30 mins. After centrifugation, two layers of RBCs are present; 
those having a density of less than the 1.105 g ml Percoll solution will 
appear at the top of the tube and represent those RBCs having the lowest 
density; these RBCs are considered the younger of the RBCs in the 
original sample. Those below the higher density Percoll solution are the 
denser, or aged, RBCs. These separates RBC fractions were removed by 
pipette. 
2.4 Determination of GSH and GSSG to reveal oxidative stress: 
Standard preparation of Glutathione (oxidized and reduced) 
1.6 gm of standard Glutathione oxidized (GSH) and Glutathione reduced 
(GSSG) was weighed separately in two different tubes. To this 2 ml of 
0.1% trifluoro acetic acid (TFA) was added. 0.1% of TFA was prepared 
by adding 100µl of TFA in 100 ml of HPLC grade filtered water. From 
these standard solutions 6 different dilutions was made of various 
concentrations to obtain a standard graph for both GSH and GSSG.  










1. 1.6 1.6       2            800 
2. 1 ml of 1. 1 ml of 1.       1             400 
3. 1 ml of 2. 1 ml of 2.       1             200 
4. 1 ml of 3. 1 ml of 3.       1            100 
5. 1 ml of 4. 1 ml of 4.       1            50 
6. 1 ml of 5. 1 ml of 5.       1            25 
2.5 HPLC analysis: 
2.5.1 Standard graph for GSH and GSSG 
Separation was achieved by C18 column. The mobile phase 
used was 100% Methanol (HPLC grade) and 0.1% Trifluoro acetic acid 
(TFA). Initial solvent conditions was maintained at 100% TFA, 0% 
Methanol at 1 ml/min for 10 mins. A linear gradient for 90% TFA, 10% 
Methanol from 10 to 30 mins was made. From 30 to 120 mins, the 
conditions are maintained at 90% TFA, 10% methanol. The samples 
were then loaded; GSH and GSSG eluted from the column are detected at 
210 nm. Typical injection volume in HPLC is 20 µl done by the help of 
Hamilton 20 ml syringe. The retention time for the oxidized and reduced 
glutathione are recorded. A standard graph was obtained for both GSH 
and GSSG. 
2.5.2 Sample analysis: 
Perchloric acid was made by adding 3.5 ml PCA in a tube and 
making up the volume upto 100 ml with distilled water. 200 µl of blood 
sample was taken and mixed with 700 µl of PCA in a centrifuge tube and 
centrifuged in a micro centrifuge for 15 mins at 11,000 RPM at 40 C. The 
pellet was discarded and the supernatant was removed by the help of 
pipette in a different centrifuge tube. This supernatant solution is then 
used for injection in HPLC. 
 
3. Results 
Standard graph was obtained by the various dilutions and the 
concentration of each samples were calculated by the help of standard 
graph. 
Table 2: Peak area obtained for various concentrations of GSSG 
SI. No Concentration (µg/ml) Area (mV/sec) 
1. 0 0 
2. 25 443.23 
3. 50 860.28 
4. 100 1628.9 
5. 200 3282.84 
6. 400 6756.11 
7. 800 13712.8 
 
Figure 1: Standard Graph for GSSG 
 
The concentrations of the levels of GSSG present in the SC 
blood sample were calculated by the help of the standard graph. 
Table 2.1: Concentration of GSSG in Sickle Cell blood sample 
SI. No Area (mV/sec) Concentration (µg/ml) 
1. 513.037 30.08485 
2. 758.02 44.45083 
3. 977.07 57.29608 
4. 349.21 20.47792 
5. 1297.67 76.09629 
6. 350.25 20.53891 
7. 678.8 39.80531 
8. 778.23 45.63596 
9. 967.89 56.75776 
10. 911.71 53.46332 
Mean concentration of GSSG was found to be 44.42 µg/ml 
The concentration of the levels of GSSG present in the normal 
blood sample was calculated by the help of the standard graph 
Table 2.2 Concentration of GSSG in normal blood sample 
SI No. Area (mV/sec) Concentration (µg/ml) 
1. 378.3 22.18378 
2. 158.05 9.268164 
3. 163.73 9.601243 
4. 30.81 1.80672 
5. 32.84 1.925761 
6. 162.53 9.530874 
7. 94 5.512227 
8. 278.09 16.30739 
9. 316.36 18.55157 
10. 183.99 10.7893 
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Standard graph was obtained by the various dilutions and the 
concentration of each samples were calculated by the help of the 
standard graph      
 
Table 2.3 Peak area obtained for various concentrations of GSH 
SI. No Concentration (µg/ml) Area (mV/sec) 
       1. 0 0 
       2. 25 343.82 
       3. 50 813.50 
       4. 100 1460.34 
       5. 200 3132.81 
       6. 400 6232.25 
       7. 800 13240.10 
 
Figure 2: Standard curve for GSH 
 
The concentration of the levels of GSH present in the SC blood 
sample was calculated by the help of the standard graph. 
 
Table 2.4 Concentration of GSH in sickle cell blood sample 
SI No. Area (mV/sec) Concentration (µg/ml) 
1. 388.97 23.85295 
2. 3637.85 223.0852 
3. 3008.85 184.4944 
4. 3456.69 211.9758 
5. 4623.44 283.5249 
6. 270.36 16.57938 
7. 4835.53 296.5309 
8. 7755.34 475.5835 
9. 6481.74 397.4821 
10. 6668.26 408.9201 
Mean concentration of GSH was found to be 252.20 µg/ml. 
 
The concentration of the levels of GSH present in the normal 
blood sample was calculated by the help of the standard graph 
 
Table 2.5 Concentration of GSH in normal blood sample 
SI No. 
 
Area (mV/sec) Concentration (µg/ml) 
1. 7107.63 435.8637 
2. 7412.67 454.5698 
3. 6389.13 391.8029 
4. 4991.2 306.0771 
5. 5735.22 351.7029 
6. 4810.6 295.0021 
7. 3191.6 195.7196 
8. 3334.19 204.4637 
9. 6120.7 375.3419 
10. 4091.9 250.929 
Mean concentration of GSH was found to be326.14 µg/ml. 
 
4. Discussion 
Sickle cell pathophysiology comprises a complex interplay of 
episodic vasoocclusive events, ischemia-reperfusion injury, over 
production of reactive oxygen species (ROS), inflammation, endothelial 
activation, and hemolysis. Hemolysis and oxidative stress act 
synergistically to promote vascular dysfunction in sickle cell disease 
(SCD). 
          A different approach is to evaluate oxidative stress as the 
analysis of antioxidant concentration. An ROS attack can lead to a major 
depletion of antioxidants such as vitamin E, vitamin C, reduced 
glutathione (GSH), and urate. The measurement of GSH, GSSG may 
therefore give fundamental information on the intracellular redox 
status. Analytical methods based on spectrophotometry, HPLC, capillary 
electrophoresis, nuclear magnetic resonance, and mass spectrometry 
have been reported for the determination of glutathione in biological 
samples. [2] 
          In order study Percoll gradients was used to fractionate 
erythrocytes on the basis of density in self-generated gradients, and 
used two different gradients of densities 1.105.g/ml and 1.115 g/ml. 
There is evidence that the colloidal silica particals of Percoll adhere to 
the surface of erythrocytes (even after washing) and cause progressive 
hemolysis; the elongation index of erythrocytes is thus difficult to 
measure and their deformability is affected. Discontinuous gradient are 
normally most easily prepared by under layering (i.e. low density first); 
over layering solutions, particularly those which differ in density by only 
a small amount, is more difficult. One alternative for over layering is to 
use a small alone (low-pulsating) peristaltic pump; first to take up the 
required volume of solution into the attached tubing and second, reverse 
the flow, to expel it slowly on to a denser layer in the centrifuge tube. [3] 
In our study RBCs were separated into fractions based on cell density 
centrifugation. In a 15ml tube, 2 ml of a similar solution of Percoll having 
density solution. Finally, 1 ml of RBCs was then centrifuged at 7500 RPM 
for 30 mins. After centrifugation, two layers of RBCs are present; those 
having a density of less than the 1.105 g ml Percoll solution will appear 
at the top of the tube and represent those RBCs having the lowest 
density; these RBCs are considered the “younger” of the RBCs in the 
original RBC sample. Those below the higher density Percoll solution are 
the more dense, or aged, RBCs. These separated RBC fractions were 
removed by pipette and diluted to a hematocrit of 7% using the PBS 
solution. GSH and GSSG levels were then measured with the help of 
HPLC. [4] 
        HPLC method was used to measure the concentration of 
reduced (GSH) and oxidized (GSSG) glutathione in the normal (healthy) 
and Sickle Cell Disease patients. We made use of the standard GSH and 
GSSG for calculating the amount present in the samples. The detection 
limit was found out to be 4 min for GSH and 6 min for GSSG at an UV 
range of 210 nm and flow rate at 1ml/min. We made a gradient of 2 
different mobile phase i.e. 90% TFA and 10% Methanol and run the 
sample for 10 min and found out the concentration of GSH and GSSG in 
30 different samples (15 Normal Healthy individuals; 15 Sickle Cell 
Disease patients). The A mean concentration of GSH in blood sample of 
15 healthy individuals was found out to be 361.45 µg/ml and in 15 
Sickle Cell disease patients was found out as 248.67 µg/ml. Also the 
mean concentration of GSSG in blood sample of 15 healthy individuals 
was found out to be 11.03 µg/ml. And in 15 Sickle Cell Disease patients 
as 39.20 µg/ml. Blood GSSG but not GSH was found significantly higher 
in Sickle Cell Disease patients as compared to normal healthy 
individuals. [4] 
 
5. Summary and conclusion 
Sickle cell pathophysiology comprises a complex interplay of 
episodic vasoocclusive events, ischemia- reperfusion injury, and 
overproduction of reactive oxygen species (ROS), inflammation, 
endothelial activation and hemolysis, all somehow driven by a single 
amino acid substitution in the β-globin chain of hemoglobin. Hemolysis 
and oxidative stress act synergistically to promote vascular dysfunction 
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individuals are subjected to high oxidative stress and, hence, stiffening 
of the cell membrane due to oxidation of important membrane proteins. 
This effect is pronounced in RBCs where G6PD is the sole producer of 
NADPH, an essential cofactor in the antioxidant defense mechanism. 
Oxidative stress may thus play a role in the pathophysiology of the 
clinical manifestations of the disease. A different approach is to evaluate 
oxidative stress as the analysis of antioxidant concentrations. An ROS 
attack can lead to a major depletion of antioxidants such as vitamin E, 
vitamin C, reduced glutathione (GSH), and urate. GSH can be oxidized, 
mainly to glutathione disulfide (GSSG), or can form glutathionylated 
proteins (PSSG). The measurement of GSG, GSSG give fundamental 
information on the intracellular redox status. Analytical methods based 
on spectrophotometry, HPLC, capillary electrophoresis, nuclear 
magnetic resonance, and mass spectrometry have been reported for the 
determination of glutathione in biological samples. 
          Our study has concluded that the HPLC method to measure 
the concentration of reduced (GSH) and oxidized (GSSG) glutathione in 
the normal (healthy) and Sickle Cell Disease patients. Erythrocyte 
glutathione depletion has been linked to hemolysis and oxidative stress. 
Our study revealed that the total antioxidant status in steady-state sickle 
cell disease (SCD) patients and compared it with some healthy 
individuals and related it to certain hematological parameters and their 
recent clinical history. 15 (males & females) adult SCD patients and 15 
age-matched controls were studied. And we hypothesized that altered 
glutathione and glutamine metabolism play a role in this process. 
         Total glutathione (oxidized & reduced) were assayed in 
erythrocytes of 15 SCD patients and 15 healthy volunteers. Erythrocyte 
glutathione levels were significantly lower in SCD patients than in 
healthy volunteers. The ratio of erythrocyte GSH: GSSG correlated 
inversely to the oxidized levels of the erythrocytes.   
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